Cite
HARVARD Citation
Fehling, S. et al. (2020). The combination of BET and PARP inhibitors is synergistic in models of cholangiocarcinoma. Cancer letters. pp. 48-58. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Fehling, S. et al. (2020). The combination of BET and PARP inhibitors is synergistic in models of cholangiocarcinoma. Cancer letters. pp. 48-58. [Online].